Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

If I could only buy 1 FTSE 100 stock, I’d put 100% of my money into this one

| Charlie Carman

Investing my entire portfolio in a single FTSE 100 stock is a very risky strategy, but if I had to…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Is now the time to buy this FTSE 100 outperformer on the dip?

| Simon Watkins

AstraZeneca shares have dipped from their previous high this year, but a new deal highlights that now might be the…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

If I’d invested £1,000 in AstraZeneca shares five years ago, here’s what I’d have now

| Cliff D'Arcy

AstraZeneca shares have been the FTSE 100's standout star over the past five years. But how much would I have…

Read more »

Girl and father putting coin into piggy bank, sitting on sofa at home
Investing Articles

1 cheap FTSE 100 share to buy in April

| Charlie Carman

Plenty of FTSE 100 shares currently look undervalued to our writer, but this UK stock market giant deserves special attention.

Read more »

Young female analyst working at her desk in the office
Investing Articles

1 of the best FTSE 100 shares to buy in a recession?

| Zaven Boyrazian, CFA

Zaven Boyrazian identifies one FTSE 100 company whose shares may be primed to thrive in the long run, even if…

Read more »

Young female analyst working at her desk in the office
Investing Articles

Should investors buy the AstraZeneca share price dip?

| Kevin Godbold

The AstraZeneca share price is down a bit, and here’s why I think it's enough for investors to become interested…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

Best British shares to buy in March

| The Motley Fool Staff

We asked our writers to share their ‘best of British’ stocks to buy this month, including a couple of well-known…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

What would a £300 investment in AstraZeneca shares made 3 years ago be worth now?

| James J. McCombie

If I had invested in AstraZeneca shares three years ago, I would be sitting pretty right now. But how about…

Read more »

A young Asian woman holding up her index finger
Investing Articles

1 FTSE 100 share I’d put 100% of my money into

| Harshil Patel

Picking just one FTSE 100 stock to buy is a challenge. Our writer racks his brain to find his number…

Read more »

Smartly dressed middle-aged black gentleman working at his desk
Investing Articles

3 cheap UK shares I’d buy to help protect my portfolio in a recession

| Charlie Carman

Defensive UK shares can outperform in challenging economic conditions. Our writer explores three stocks he'd buy in a recession.

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

These three FTSE 100 stocks have huge upside

| Ryan Hogg

Ryan Hogg identifies a trio of FTSE 100 stocks that not only pay a dividend yield of more than 2%…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Here’s the AstraZeneca dividend forecast for 2023

| Edward Sheldon, CFA

Here, Edward Sheldon looks at the AstraZeneca dividend forecast for this year with the pharma giant slowly increasing its dividend…

Read more »